Skip to content

Clinical trials

Completed Phase 1/2 Waldenstrom Macroglobulinemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Phase: Phase 1/2 Status: Completed Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20034
20041
20053
20073
20081
20094
20101
20113
20121
20142
20151
20161
20171
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Fred Hutchinson Cancer Center4
Mayo Clinic4
Memorial Sloan Kettering Cancer Center2
UNC Lineberger Comprehensive Cancer Center2
Acerta Pharma BV1
Acrotech Biopharma Inc.1
Asan Medical Center1
BeiGene1
Beth Christian1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia36
Leukemia, Lymphocytic, Chronic, B-Cell26
Lymphoma, Follicular26
Lymphoma, B-Cell, Marginal Zone25
Lymphoma, Mantle-Cell25
Lymphoma, Large B-Cell, Diffuse19
Lymphoma, Non-Hodgkin19
Burkitt Lymphoma17
Hodgkin Disease17
Lymphoma14

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.